Using room sensors to spot early warnings for hospitalized cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This study uses special sensors in patient rooms to monitor movement and other signals that might show early signs of medical problems. The goal is to see if these sensors can help doctors and nurses step in sooner for cancer patients in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a history of cancer or a current cancer diagnosis.
- You are not receiving comfort or end-of-life care.
- Your primary language is English.
- You are staying in one of the rooms that has the special sensors installed.
- You are NOT in jail or prison.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a wearable activity tracker during radiation therapy can help reduce hospitalizations. It may help you stay healthier during treatment.
This study tests a remote patient monitoring program for people with cancer who are starting treatment. It aims to see if monitoring from home can improve care and support.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This study tests new wireless body sensors that can keep track of your breathing and heart rate while you're in the hospital. The goal is to see if these sensors can alert doctors earlier when your condition might be getting worse.
This study looks at whether information from wearable devices can help doctors better care for patients receiving chemotherapy and radiation together. It aims to improve treatment and quality of life.
This study tests a system where you report your symptoms online or by phone from home. A nurse will call you to help manage any side effects of your treatment.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.